Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Xiuju Yan"'
Autor:
Shengnan Tang, Aiping Wang, Xiuju Yan, Liuxiang Chu, Xiucheng Yang, Yina Song, Kaoxiang Sun, Xin Yu, Rongxia Liu, Zimei Wu, Peng Xue
Publikováno v:
Drug Delivery, Vol 26, Iss 1, Pp 700-707 (2019)
Efficient delivery of brain-targeted drugs is highly important for successful therapy in Parkinson’s disease (PD). This study was designed to formulate borneol and lactoferrin co-modified nanoparticles (Lf-BNPs) encapsulated dopamine as a novel dru
Externí odkaz:
https://doaj.org/article/88fa8751d7d749edafc991324c85bb2a
Autor:
Ying Jiang, Xuemei Zhang, Hongjie Mu, Hongchen Hua, Dongyu Duan, Xiuju Yan, Yiyun Wang, Qingqing Meng, Xiaoyan Lu, Aiping Wang, Wanhui Liu, Youxin Li, Kaoxiang Sun
Publikováno v:
Drug Delivery, Vol 25, Iss 1, Pp 143-152 (2018)
A microsphere–gel in situ forming implant (MS–Gel ISFI) dual-controlled drug delivery system was applied to a high water-soluble small-molecule compound Rasagiline mesylate (RM) for effective treatment of Parkinson’s disease. This injectable co
Externí odkaz:
https://doaj.org/article/63bffde498054c508b9ff68888de9403
Autor:
Liuxiang Chu, Aiping Wang, Ling Ni, Xiuju Yan, Yina Song, Mingyu Zhao, Kaoxiang Sun, Hongjie Mu, Sha Liu, Zimei Wu, Chunyan Zhang
Publikováno v:
Drug Delivery, Vol 25, Iss 1, Pp 1634-1641 (2018)
Glioblastoma is the most common malignant brain tumor. Efficient delivery of drugs targeting glioblastomas remains a challenge. Ephrin type-A receptor 3 (EPHA3) tyrosine kinase antibody-modified polylactide-co-glycolide (PLGA) nanoparticles (NPs) wer
Externí odkaz:
https://doaj.org/article/08711b245c7d47d19999f4fde88557be
Autor:
Kaoxiang Sun, Chunjie Sha, Shengnan Tang, Nuannuan Li, Aiping Wang, Yawen Yu, Yanan Lv, Youxin Li, Xiuju Yan, Liangxiao Wang
Publikováno v:
Molecular Pharmaceutics. 18:915-927
Glioblastoma multiforme (GBM) is a highly lethal and aggressive tumor of the brain that carries a poor prognosis. Temozolomide (TMZ) has been widely used as a first-line treatment for GBM. However, poor brain targeting, side effects, and drug resista
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ef3a75971f768696fd1892e0be97d47
https://doi.org/10.1021/acs.molpharmaceut.0c00911
https://doi.org/10.1021/acs.molpharmaceut.0c00911
Publikováno v:
Pharmaceutical Development and Technology. 24:1229-1235
Exenatide (EX), a glucagon-like peptide-1 receptor agonist, is used to treat diabetes mellitus. However, its short half-life necessitates frequent administration and fluctuations in its plasma concentration may cause adverse effects. Previously, we d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea4584fcce548aa634921b337d6972c1
https://doi.org/10.1080/10837450.2019.1651857
https://doi.org/10.1080/10837450.2019.1651857
Autor:
Xuemei Zhang, Xiuju Yan, Yanan Shi, Haiyan Hu, Liping Zhang, Mingyu Zhao, Yina Song, Miaomiao Yin, Chunyan Zhang, Liuxiang Chu, Kaoxiang Sun, Hongjie Mu
Publikováno v:
Molecular Pharmaceutics. 16:518-532
The oral absorption of exenatide, a drug for type 2 diabetes treatment, can be improved by using nanoparticles (NPs) for its delivery. To improve the mucus penetration and intestinal absorption of exenatide, we designed a block copolymer, CSKSSDYQC-d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10c3e22782a81e71a79a3448114a4134
https://doi.org/10.1021/acs.molpharmaceut.8b00809
https://doi.org/10.1021/acs.molpharmaceut.8b00809
Autor:
Dongyu Duan, Ying Jiang, Ling Ni, Xiuju Yan, Zimei Wu, Hongjie Mu, Liping Zhang, Youxin Li, Aiping Wang, Kaoxiang Sun
Publikováno v:
International Journal of Nanomedicine
Dongyu Duan,1,* Aiping Wang,1,* Ling Ni,2 Liping Zhang,1 Xiuju Yan,1 Ying Jiang,1 Hongjie Mu,1 Zimei Wu,1 Kaoxiang Sun,1 Youxin Li1,2 1School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a066be1753a738ca501183c7d7430589
https://doi.org/10.2147/ijn.s153795
https://doi.org/10.2147/ijn.s153795
Autor:
Xiucheng Yang, Liuxiang Chu, Xin Yu, Shengnan Tang, Xiuju Yan, Kaoxiang Sun, Rongxia Liu, Zimei Wu, Aiping Wang, Yina Song, Peng Xue
Publikováno v:
Drug Delivery
Drug Delivery, Vol 26, Iss 1, Pp 700-707 (2019)
Drug Delivery, Vol 26, Iss 1, Pp 700-707 (2019)
Efficient delivery of brain-targeted drugs is highly important for successful therapy in Parkinson’s disease (PD). This study was designed to formulate borneol and lactoferrin co-modified nanoparticles (Lf-BNPs) encapsulated dopamine as a novel dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e88d1d3ef4c3975e153253d7435e8ec8
Autor:
Dongyu Duan, Kaoxiang Sun, Zimei Wu, Aiping Wang, Lixiao Xu, Xiuju Yan, Xin Yu, Chenchen Bi, Liuxiang Chu
Publikováno v:
International Journal of Nanomedicine
Xiuju Yan,1,* Lixiao Xu,1,* Chenchen Bi,1 Dongyu Duan,1 Liuxiang Chu,1 Xin Yu,1 Zimei Wu,1 Aiping Wang,1,2 Kaoxiang Sun1,2 1School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69d1ff0a8119f17a5e394090cc024b2d
https://pubmed.ncbi.nlm.nih.gov/29391788
https://pubmed.ncbi.nlm.nih.gov/29391788
Autor:
Youxin Li, Kaoxiang Sun, Xiuju Yan, Hongjie Mu, Dongyu Duan, Hongchen Hua, Aiping Wang, Ying Jiang, Wanhui Liu, Xuemei Zhang, Yiyun Wang, Xiaoyan Lu, Qingqing Meng
Publikováno v:
Drug Delivery
Drug Delivery, Vol 25, Iss 1, Pp 143-152 (2018)
Drug Delivery, Vol 25, Iss 1, Pp 143-152 (2018)
A microsphere–gel in situ forming implant (MS–Gel ISFI) dual-controlled drug delivery system was applied to a high water-soluble small-molecule compound Rasagiline mesylate (RM) for effective treatment of Parkinson’s disease. This injectable co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5645a3ebcc0e17aab5d892d6bc64ec7e